Literature DB >> 23880794

How well do different measurement modalities estimate the number of vasomotor symptoms? Findings from the Study of Women's Health Across the Nation FLASHES Study.

Polly Fu1, Karen A Matthews, Rebecca C Thurston.   

Abstract

OBJECTIVE: Studies of vasomotor symptoms (VMS) typically measure VMS via daily diaries completed at the end of the day. VMS can also be measured via diaries completed throughout the day or via physiological monitors-modalities with lower recall demands. We examined the degree of correspondence between three VMS measurement modalities: retrospective end-of-day/morning diaries, prospective reporting, and physiological monitoring. We determined whether discrepancies between measurement modalities varied by participant characteristics.
METHODS: Twenty-five African-American women and 27 white women from the Pittsburgh site of the Study of Women's Health Across the Nation who were experiencing VMS, had intact uterus and ovaries, and were free of medications affecting VMS underwent 4 days of ambulatory VMS and Actiwatch monitoring. VMS were recalled in end-of-day and morning diaries, reported prospectively during the day, and measured physiologically via a hot flash monitor. Associations between anxiety, sleep, or race/ethnicity and VMS measurement modality difference scores were examined using generalized estimating equations.
RESULTS: Women underestimated the number of daytime VMS at the end of the day as compared with VMS that were prospectively reported or physiologically measured throughout the day. This pattern was particularly pronounced among African-American women (b [SE] = -3.01 [0.93], P = 0.001) and women with higher anxiety (b [SE] = -3.13 [1.53], P = 0.04). For nighttime VMS, women overestimated the number of VMS in the morning upon waking as compared with prospective measures, particularly if they had poorer sleep (higher wakening after sleep onset: b [SE] = 0.03 [0.008], P = 0.001).
CONCLUSIONS: Different measurement modalities yield different VMS estimates. Negative affect, sleep, and race/ethnicity may affect the recall of VMS.

Entities:  

Mesh:

Year:  2014        PMID: 23880794      PMCID: PMC3812392          DOI: 10.1097/GME.0b013e318295a3b9

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  39 in total

1.  Relationships between menopausal and mood symptoms and EEG sleep measures in a multi-ethnic sample of middle-aged women: the SWAN sleep study.

Authors:  Howard M Kravitz; Elizabeth Avery; Maryfran Sowers; Joyce T Bromberger; Jane F Owens; Karen A Matthews; Martica Hall; Huiyong Zheng; Ellen B Gold; Daniel J Buysse
Journal:  Sleep       Date:  2011-09-01       Impact factor: 5.849

2.  Are vasomotor symptoms associated with sleep characteristics among symptomatic midlife women? Comparisons of self-report and objective measures.

Authors:  Rebecca C Thurston; Nanette Santoro; Karen A Matthews
Journal:  Menopause       Date:  2012-07       Impact factor: 2.953

3.  The symptom perception hypothesis revised: depression and anxiety play different roles in concurrent and retrospective physical symptom reporting.

Authors:  M Bryant Howren; Jerry Suls
Journal:  J Pers Soc Psychol       Date:  2011-01

Review 4.  Anxiety during the menopausal transition: a systematic review.

Authors:  Christina Bryant; Fiona K Judd; Martha Hickey
Journal:  J Affect Disord       Date:  2011-07-23       Impact factor: 4.839

5.  The role of anxiety and hormonal changes in menopausal hot flashes.

Authors:  Ellen W Freeman; Mary D Sammel; Hui Lin; Clarisa R Gracia; Shiv Kapoor; Tahmina Ferdousi
Journal:  Menopause       Date:  2005 May-Jun       Impact factor: 2.953

6.  Role of ethnicity in the expression of features of hot flashes.

Authors:  James W Simpkins; Kimberly Brown; Sejong Bae; Anna Ratka
Journal:  Maturitas       Date:  2009-07-09       Impact factor: 4.342

7.  Healthcare seeking and treatment for menopausal symptoms in the United States.

Authors:  Rachel E Williams; Linda Kalilani; Dana Britt DiBenedetti; Xiaolei Zhou; Sheri E Fehnel; Richard V Clark
Journal:  Maturitas       Date:  2007-10-25       Impact factor: 4.342

8.  Beyond frequency: who is most bothered by vasomotor symptoms?

Authors:  Rebecca C Thurston; Joyce T Bromberger; Hadine Joffe; Nancy E Avis; Rachel Hess; Carolyn J Crandall; Yuefang Chang; Robin Green; Karen A Matthews
Journal:  Menopause       Date:  2008 Sep-Oct       Impact factor: 2.953

9.  Effect of escitalopram on hot flash interference: a randomized, controlled trial.

Authors:  Janet S Carpenter; Katherine A Guthrie; Joseph C Larson; Ellen W Freeman; Hadine Joffe; Susan D Reed; Kristine E Ensrud; Andrea Z LaCroix
Journal:  Fertil Steril       Date:  2012-04-03       Impact factor: 7.490

10.  Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial.

Authors:  Ellen W Freeman; Katherine A Guthrie; Bette Caan; Barbara Sternfeld; Lee S Cohen; Hadine Joffe; Janet S Carpenter; Garnet L Anderson; Joseph C Larson; Kristine E Ensrud; Susan D Reed; Katherine M Newton; Sheryl Sherman; Mary D Sammel; Andrea Z LaCroix
Journal:  JAMA       Date:  2011-01-19       Impact factor: 157.335

View more
  11 in total

1.  Characterizing the trajectories of vasomotor symptoms across the menopausal transition.

Authors:  Ping G Tepper; Maria M Brooks; John F Randolph; Sybil L Crawford; Samar R El Khoudary; Ellen B Gold; Bill L Lasley; Bobby Jones; Hadine Joffe; Rachel Hess; Nancy E Avis; Sioban Harlow; Daniel S McConnell; Joyce T Bromberger; Huiyong Zheng; Kristine Ruppert; Rebecca C Thurston
Journal:  Menopause       Date:  2016-10       Impact factor: 2.953

2.  Measuring hot flash phenomenonology using ambulatory prospective digital diaries.

Authors:  William I Fisher; Rebecca C Thurston
Journal:  Menopause       Date:  2016-11       Impact factor: 2.953

3.  Childhood abuse and vasomotor symptoms among midlife women.

Authors:  Mary Y Carson; Rebecca C Thurston
Journal:  Menopause       Date:  2019-10       Impact factor: 2.953

4.  Menopausal Hot Flashes and Carotid Intima Media Thickness Among Midlife Women.

Authors:  Rebecca C Thurston; Yuefang Chang; Emma Barinas-Mitchell; J Richard Jennings; Doug P Landsittel; Nanette Santoro; Roland von Känel; Karen A Matthews
Journal:  Stroke       Date:  2016-11-10       Impact factor: 7.914

Review 5.  Vasomotor symptoms: natural history, physiology, and links with cardiovascular health.

Authors:  R C Thurston
Journal:  Climacteric       Date:  2018-02-02       Impact factor: 3.005

6.  Sleep characteristics and inflammatory biomarkers among midlife women.

Authors:  Sara Nowakowski; Karen A Matthews; Roland von Känel; Martica H Hall; Rebecca C Thurston
Journal:  Sleep       Date:  2018-05-01       Impact factor: 5.849

7.  Behavioral weight loss for the management of menopausal hot flashes: a pilot study.

Authors:  Rebecca C Thurston; Linda J Ewing; Carissa A Low; Aimee J Christie; Michele D Levine
Journal:  Menopause       Date:  2015-01       Impact factor: 2.953

8.  Physiologically assessed hot flashes and endothelial function among midlife women.

Authors:  Rebecca C Thurston; Yuefang Chang; Emma Barinas-Mitchell; J Richard Jennings; Roland von Känel; Doug P Landsittel; Karen A Matthews
Journal:  Menopause       Date:  2017-08       Impact factor: 3.310

9.  Genetic variants predictive of reproductive aging are associated with vasomotor symptoms in a multiracial/ethnic cohort.

Authors:  Wei Zhao; Jennifer A Smith; Miao Yu; Carolyn J Crandall; Rebecca C Thurston; Michelle M Hood; Edward Ruiz-Narvaez; Patricia A Peyser; Sharon L R Kardia; Sioban D Harlow
Journal:  Menopause       Date:  2021-04-26       Impact factor: 3.310

10.  Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS).

Authors:  Dahima Cintron; Brian D Lahr; Kent R Bailey; Nanette Santoro; Robin Lloyd; JoAnn E Manson; Genevieve Neal-Perry; Lubna Pal; Hugh S Taylor; Whitney Wharton; Fredrick Naftolin; S Mitchell Harman; Virginia M Miller
Journal:  Menopause       Date:  2018-02       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.